Celeste Clark - Prestige Brand Independent Director
| PBH Stock | USD 71.26 0.14 0.20% |
Director
Celeste Clark is Independent Director of Prestige Brand Holdings since 2021.
| Age | 67 |
| Tenure | 3 years |
| Address | 660 White Plains Road, Tarrytown, NY, United States, 10591 |
| Phone | 914 524 6800 |
| Web | https://www.prestigebrands.com |
Prestige Brand Management Efficiency
The company has Return on Asset of 0.0616 % which means that on every $100 spent on assets, it made $0.0616 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0491) %, meaning that it generated no profit with money invested by stockholders. Prestige Brand's management efficiency ratios could be used to measure how well Prestige Brand manages its routine affairs as well as how well it operates its assets and liabilities. The Prestige Brand's current Return On Tangible Assets is estimated to increase to -0.15. The current Return On Capital Employed is estimated to decrease to 0.06. As of now, Prestige Brand's Total Current Assets are increasing as compared to previous years. The Prestige Brand's current Net Tangible Assets is estimated to increase to about 1.7 B, while Total Assets are projected to decrease to under 2.1 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Patricia Allen | Deciphera Pharmaceuticals LLC | 56 | |
| Edward Benz | Deciphera Pharmaceuticals LLC | 71 | |
| Michael Ross | Deciphera Pharmaceuticals LLC | 68 | |
| Michael Graves | Eagle Pharmaceuticals | 61 | |
| Douglas Braunstein | Eagle Pharmaceuticals | 57 | |
| Sander Flaum | Eagle Pharmaceuticals | 81 | |
| Liam Ratcliffe | Deciphera Pharmaceuticals LLC | 53 | |
| Edward Kay | Eagle Pharmaceuticals | N/A | |
| Robert Glenning | Eagle Pharmaceuticals | 57 | |
| Alain Schreiber | Eagle Pharmaceuticals | 58 | |
| Dennis Walsh | Deciphera Pharmaceuticals LLC | 50 | |
| James Bristol | Deciphera Pharmaceuticals LLC | 71 | |
| David Pernock | Eagle Pharmaceuticals | 63 | |
| Richard Edlin | Eagle Pharmaceuticals | 57 | |
| John Martin | Deciphera Pharmaceuticals LLC | 57 | |
| Susan Kelley | Deciphera Pharmaceuticals LLC | 63 | |
| Steven Ratoff | Eagle Pharmaceuticals | 81 | |
Management Performance
| Return On Equity | -0.0491 | ||||
| Return On Asset | 0.0616 |
Prestige Brand Holdings Leadership Team
Elected by the shareholders, the Prestige Brand's board of directors comprises two types of representatives: Prestige Brand inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Prestige. The board's role is to monitor Prestige Brand's management team and ensure that shareholders' interests are well served. Prestige Brand's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Prestige Brand's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charles Hinkaty, Independent Director | ||
| Jeffrey Zerillo, Senior Vice President Operations | ||
| Adel Mekhail, Executive Vice President - Sales and Marketing | ||
| Thomas Hochuli, VP of Operations | ||
| Ronald Lombardi, Chairman of the Board, President, Chief Executive Officer | ||
| Dawn Zier, Independent Director | ||
| Jean Boyko, Senior Vice President - Science and Technology | ||
| David Marberger, CFO | ||
| Philip Terpolilli, Director Relations | ||
| Christopher Heye, Senior Vice President , Strategic Planning, Canada, and Women’s Health | ||
| John Parkinson, Sr. VP of International | ||
| Paul Migaki, Vice President - Strategic Planning, Canada and Household | ||
| Mary Fritz, Senior Affairs | ||
| James Jenness, Independent Director | ||
| Timothy Connors, Executive VP of Sales and Marketing | ||
| Carl Johnson, Independent Director | ||
| Dean Siegal, Director Communications | ||
| John Byom, Independent Director | ||
| Gary Costley, Lead Independent Director | ||
| William PPool, Senior Vice President General Counsel and Corporate Secretary | ||
| Christopher Coughlin, Independent Director | ||
| Christine Sacco, Chief Financial Officer | ||
| Sheila Hopkins, Independent Director | ||
| Natale Ricciardi, Independent Director | ||
| Samuel Cowley, VP of Bus. Devel., General Counsel and Secretary | ||
| Celeste Clark, Independent Director |
Prestige Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Prestige Brand a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0491 | ||||
| Return On Asset | 0.0616 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 4.68 B | ||||
| Shares Outstanding | 49.65 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 98.80 % | ||||
| Number Of Shares Shorted | 1.83 M | ||||
| Price To Earning | 18.23 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Prestige Brand Holdings using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prestige Brand Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Prestige Brand Holdings information on this page should be used as a complementary analysis to other Prestige Brand's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Prestige Stock analysis
When running Prestige Brand's price analysis, check to measure Prestige Brand's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prestige Brand is operating at the current time. Most of Prestige Brand's value examination focuses on studying past and present price action to predict the probability of Prestige Brand's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prestige Brand's price. Additionally, you may evaluate how the addition of Prestige Brand to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Prestige Brand's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prestige Brand. If investors know Prestige will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prestige Brand listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.019 | Earnings Share (1.61) | Revenue Per Share 22.8 | Quarterly Revenue Growth 0.026 | Return On Assets 0.0616 |
The market value of Prestige Brand Holdings is measured differently than its book value, which is the value of Prestige that is recorded on the company's balance sheet. Investors also form their own opinion of Prestige Brand's value that differs from its market value or its book value, called intrinsic value, which is Prestige Brand's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prestige Brand's market value can be influenced by many factors that don't directly affect Prestige Brand's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prestige Brand's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prestige Brand is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prestige Brand's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.